EE200200637A - Torasemiidi uudne polümorf V, selle valmistamismeetod, kasutamine ja ravimvorm - Google Patents

Torasemiidi uudne polümorf V, selle valmistamismeetod, kasutamine ja ravimvorm

Info

Publication number: EE200200637A
Authority: EE; Estonia
Prior art keywords: torasemide; preparation; dosage form; novel polymorph; polymorph
Prior art date: 2000-05-19

Application number

EEP200200637A

Other languages

English (en)

Estonian (et)

Inventor

Filic Darko

Dumic Miljenko

Klepic Bozena

Danilovski Aleksandar

Tudja Marijan

Original Assignee

PLIVA, farmaceutska industrija, dionicko dru�tvo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-19

Filing date

2000-09-25

Publication date

2004-04-15

2000-09-25 Application filed by PLIVA, farmaceutska industrija, dionicko dru�tvo filed Critical PLIVA, farmaceutska industrija, dionicko dru�tvo

2004-04-15 Publication of EE200200637A publication Critical patent/EE200200637A/xx

Links

NGBFQHCMQULJNZ-UHFFFAOYSA-N Torsemide Chemical compound CC(C)NC(=O)NS(=O)(=O)C1=CN=CC=C1NC1=CC=CC(C)=C1 NGBFQHCMQULJNZ-UHFFFAOYSA-N 0.000 title 1
239000002552 dosage form Substances 0.000 title 1
229960005461 torasemide Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Otolaryngology (AREA)
Hospice & Palliative Care (AREA)
Endocrinology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)

EEP200200637A 2000-05-19 2000-09-25 Torasemiidi uudne polümorf V, selle valmistamismeetod, kasutamine ja ravimvorm EE200200637A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HR20000328A HRP20000328A2 (en)	2000-05-19	2000-05-19	Novel polymorph v of torasemide
PCT/HR2000/000033 WO2001087841A1 (en)	2000-05-19	2000-09-25	Novel polymorph v of torasemide

Publications (1)

Publication Number	Publication Date
EE200200637A true EE200200637A (et)	2004-04-15

Family

ID=10947111

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200637A EE200200637A (et)	2000-05-19	2000-09-25	Torasemiidi uudne polümorf V, selle valmistamismeetod, kasutamine ja ravimvorm

Country Status (32)

Country	Link
US (2)	US7241782B1 (de)
EP (1)	EP1283828B1 (de)
JP (1)	JP2003533512A (de)
KR (1)	KR20030016267A (de)
CN (1)	CN1520403A (de)
AP (1)	AP2002002679A0 (de)
AR (1)	AR028840A1 (de)
AT (1)	ATE342890T1 (de)
AU (1)	AU2000274381A1 (de)
BG (1)	BG107407A (de)
BR (1)	BR0015877A (de)
CA (1)	CA2409699A1 (de)
CZ (1)	CZ20024104A3 (de)
DE (1)	DE60031450T2 (de)
DZ (1)	DZ3356A1 (de)
EA (1)	EA005003B1 (de)
EE (1)	EE200200637A (de)
GE (1)	GEP20043321B (de)
HR (1)	HRP20000328A2 (de)
HU (1)	HUP0302135A2 (de)
IL (1)	IL152810A0 (de)
IS (1)	IS6620A (de)
MA (1)	MA25748A1 (de)
MX (1)	MXPA02011402A (de)
NO (1)	NO20025509D0 (de)
NZ (1)	NZ522544A (de)
PL (1)	PL358257A1 (de)
SK (1)	SK17712002A3 (de)
TR (1)	TR200202544T2 (de)
WO (1)	WO2001087841A1 (de)
YU (1)	YU84202A (de)
ZA (1)	ZA200209181B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20020025217A (ko) *	1999-08-11	2002-04-03	추후보정	토르세미드 동질이상
IN192178B (de) *	2001-08-03	2004-03-06	Ranbaxy Lab
US7067385B2 (en) *	2003-09-04	2006-06-27	Micron Technology, Inc.	Support for vertically oriented capacitors during the formation of a semiconductor device
CN1824647B (zh) *	2005-02-22	2011-04-20	田边三菱制药株式会社	(±)2-(二甲基氨基)-1-{[O-(m-甲氧基苯乙基)苯氧基]甲基}乙基氢琥珀酸酯盐酸盐的晶体
CN100421662C (zh) *	2005-11-08	2008-10-01	周卓和	托拉塞米分散片及其制备方法和应用
CN104370805B (zh) *	2013-08-13	2016-09-07	天津汉瑞药业有限公司	托拉塞米化合物
CN105949115A (zh) *	2016-05-26	2016-09-21	南京正科医药股份有限公司	一种新晶型托拉塞米
CN115417810B (zh) *	2022-09-22	2023-10-10	南京正科医药股份有限公司	一种托拉塞米晶型ⅰ的精制方法
CN117486789A (zh) *	2023-12-29	2024-02-02	江西中医药大学	一种托拉塞米共晶盐及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1477664A (en) *	1974-04-17	1977-06-22	Christiaens Sa A	Pyridine derivatives
US4055650A (en)	1974-04-17	1977-10-25	A. Christiaens Societe Anonyme	Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
US4476248A (en) *	1983-02-28	1984-10-09	The Upjohn Company	Crystallization of ibuprofen
IN182496B (de) *	1996-02-20	1999-04-17	Reddy Research Foundation
HRP980532B1 (en) *	1998-10-02	2005-06-30	Pliva	Novel crystalline torasemide modification
US5914336A (en) *	1998-06-02	1999-06-22	Boehringer Mannheim Gmbh	Method of controlling the serum solubility of orally administered torasemide and composition relating thereto

2000
- 2000-05-19 HR HR20000328A patent/HRP20000328A2/hr not_active Application Discontinuation
- 2000-06-26 AR ARP000103199A patent/AR028840A1/es unknown
- 2000-09-25 CN CNA008196567A patent/CN1520403A/zh active Pending
- 2000-09-25 YU YU84202A patent/YU84202A/sh unknown
- 2000-09-25 TR TR2002/02544T patent/TR200202544T2/xx unknown
- 2000-09-25 GE GE4998A patent/GEP20043321B/en unknown
- 2000-09-25 JP JP2001584237A patent/JP2003533512A/ja active Pending
- 2000-09-25 US US10/276,881 patent/US7241782B1/en not_active Expired - Fee Related
- 2000-09-25 MX MXPA02011402A patent/MXPA02011402A/es unknown
- 2000-09-25 HU HU0302135A patent/HUP0302135A2/hu unknown
- 2000-09-25 WO PCT/HR2000/000033 patent/WO2001087841A1/en not_active Ceased
- 2000-09-25 IL IL15281000A patent/IL152810A0/xx unknown
- 2000-09-25 DZ DZ003356A patent/DZ3356A1/fr active
- 2000-09-25 EA EA200201236A patent/EA005003B1/ru not_active IP Right Cessation
- 2000-09-25 NZ NZ522544A patent/NZ522544A/en unknown
- 2000-09-25 SK SK1771-2002A patent/SK17712002A3/sk unknown
- 2000-09-25 DE DE60031450T patent/DE60031450T2/de not_active Expired - Fee Related
- 2000-09-25 EP EP00962739A patent/EP1283828B1/de not_active Expired - Lifetime
- 2000-09-25 CA CA002409699A patent/CA2409699A1/en not_active Abandoned
- 2000-09-25 BR BR0015877-1A patent/BR0015877A/pt not_active IP Right Cessation
- 2000-09-25 AP APAP/P/2002/002679A patent/AP2002002679A0/en unknown
- 2000-09-25 AT AT00962739T patent/ATE342890T1/de not_active IP Right Cessation
- 2000-09-25 PL PL00358257A patent/PL358257A1/xx not_active Application Discontinuation
- 2000-09-25 AU AU2000274381A patent/AU2000274381A1/en not_active Abandoned
- 2000-09-25 KR KR1020027015607A patent/KR20030016267A/ko not_active Withdrawn
- 2000-09-25 EE EEP200200637A patent/EE200200637A/xx unknown
- 2000-09-25 CZ CZ20024104A patent/CZ20024104A3/cs unknown
2002
- 2002-11-11 MA MA26902A patent/MA25748A1/fr unknown
- 2002-11-12 ZA ZA200209181A patent/ZA200209181B/en unknown
- 2002-11-14 IS IS6620A patent/IS6620A/is unknown
- 2002-11-15 NO NO20025509A patent/NO20025509D0/no not_active Application Discontinuation
- 2002-12-19 BG BG107407A patent/BG107407A/xx unknown
2007
- 2007-06-14 US US11/763,156 patent/US20070238759A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0015877A (pt)	2003-04-29
SK17712002A3 (sk)	2003-05-02
NZ522544A (en)	2004-07-30
YU84202A (sh)	2006-05-25
HRP20000328A2 (en)	2002-02-28
HUP0302135A2 (hu)	2003-10-28
BG107407A (en)	2004-01-30
US20070238759A1 (en)	2007-10-11
TR200202544T2 (tr)	2003-03-21
EP1283828B1 (de)	2006-10-18
EP1283828A1 (de)	2003-02-19
MA25748A1 (fr)	2003-04-01
AP2002002679A0 (en)	2002-12-31
ZA200209181B (en)	2004-02-12
DE60031450D1 (de)	2006-11-30
CZ20024104A3 (cs)	2003-04-16
US7241782B1 (en)	2007-07-10
JP2003533512A (ja)	2003-11-11
NO20025509L (no)	2002-11-15
KR20030016267A (ko)	2003-02-26
DE60031450T2 (de)	2007-09-20
AR028840A1 (es)	2003-05-28
EA005003B1 (ru)	2004-10-28
PL358257A1 (en)	2004-08-09
ATE342890T1 (de)	2006-11-15
CA2409699A1 (en)	2001-11-22
WO2001087841A1 (en)	2001-11-22
AU2000274381A1 (en)	2001-11-26
EA200201236A1 (ru)	2003-04-24
GEP20043321B (en)	2004-04-13
CN1520403A (zh)	2004-08-11
NO20025509D0 (no)	2002-11-15
DZ3356A1 (en)	2001-11-22
IL152810A0 (en)	2003-06-24
MXPA02011402A (es)	2003-06-06
IS6620A (is)	2002-11-14

Legal Events

Date	Code	Title	Description
2005-02-15	GB1A	Change in the ownership or in the address of the owner
2005-04-15	GB1A	Change in the ownership or in the address of the owner

Publication	Publication Date	Title
EE200300587A (et)	2004-02-16	Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE200300207A (et)	2003-08-15	Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE200200704A (et)	2004-08-16	Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et)	2003-12-15	Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
LTC1345910I2 (lt)	2022-06-10	Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
EE200200486A (et)	2004-02-16	Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EE05223B1 (et)	2009-10-15	Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300581A (et)	2004-02-16	Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
EE200300054A (et)	2004-12-15	Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
PL396568A1 (pl)	2012-02-13	Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
HUP0300527A3 (en)	2012-10-29	Pyrrolopyrimidinone derivatives, process of preparation and use
EE200300327A (et)	2003-10-15	Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE200300245A (et)	2003-08-15	Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
NO20030012L (no)	2003-03-03	Fremgangsmåte for fremstilling av substituerte oktanoylamider
EE200200655A (et)	2004-08-16	5-kloro-3-(4-metaansulfonüülfenüül)-6'-metüül[2,3']bipüridinüüli polümorfne vorm, selle valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE201100023A (et)	2011-08-15	Ravimite kombinatsioon, mis sisaldab rasvhapet ja uridiin hendit, ja selle kasutamine
EE200300400A (et)	2003-12-15	Pürimidiiniühendid, nende valmistamismeetod ning kasutamine
EE200100653A (et)	2003-02-17	Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE200100574A (et)	2003-02-17	Uued ühendid, nende valmistamise meetod ning kasutamine
NO20040292L (no)	2004-03-19	Fremgangsmate for fremstilling av 4-aminodifenylamin
NO326689B1 (no)	2009-01-26	Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
EE05308B1 (et)	2010-06-15	Sulfoonamiid-asendatud imidasotriasinoonide valmistamismeetod
EE200200697A (et)	2004-08-16	Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin